advertisement
3.8 Pharmacology (83)
Showing records 1 to 25
Display all abstracts in classification 3.8 Pharmacology
Search within classification 3.8 Pharmacology91790 The vital role for nitric oxide in intraocular pressure homeostasis
Reina-Torres E
Progress in Retinal and Eye Research 2020; 0: 100922
90886 Marijuana and Glaucoma: A Social Media Content Analysis
Jia JS
Ophthalmology. Glaucoma 2021; 4: 400-404
90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Kasetti RB
Nature communications 2020; 11: 5594
91763 Can Polyphenols in Eye Drops Be Useful for Trabecular Protection from Oxidative Damage?
Saccà SC
Journal of clinical medicine 2020; 9:
91825 MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension
Canut MI
Scientific reports 2021; 11: 1583
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Takayanagi Y
Life (Basel, Switzerland) 2020; 10:
90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Li Y
Journal of chemical neuroanatomy 2020; 110: 101876
91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Edwards G
Antioxidants (Basel, Switzerland) 2020; 9:
91299 Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms
Miller S
Experimental Eye Research 2020; 200: 108241
91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Sterling JK
Cell reports 2020; 33: 108271
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Takayanagi Y
Life (Basel, Switzerland) 2020; 10:
90990 Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma
Jabbehdari S
European Journal of Ophthalmology 2020; 0: 1120672120960337
90871 Glaucoma and Antioxidants: Review and Update
Garcia-Medina JJ; Rubio-Velazquez E
Antioxidants (Basel, Switzerland) 2020; 9:
91825 MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension
Villa O
Scientific reports 2021; 11: 1583
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Takai Y
Life (Basel, Switzerland) 2020; 10:
90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Wang Q
Journal of chemical neuroanatomy 2020; 110: 101876
91763 Can Polyphenols in Eye Drops Be Useful for Trabecular Protection from Oxidative Damage?
Izzotti A
Journal of clinical medicine 2020; 9:
90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Patel PD
Nature communications 2020; 11: 5594
91299 Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms
Daily L
Experimental Eye Research 2020; 200: 108241
90886 Marijuana and Glaucoma: A Social Media Content Analysis
Mehran N
Ophthalmology. Glaucoma 2021; 4: 400-404
90990 Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma
Chen JL
European Journal of Ophthalmology 2020; 0: 1120672120960337
91790 The vital role for nitric oxide in intraocular pressure homeostasis
De Ieso ML
Progress in Retinal and Eye Research 2020; 0: 100922
90886 Marijuana and Glaucoma: A Social Media Content Analysis
Mehran N
Ophthalmology. Glaucoma 2021; 4: 400-404
91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Lee Y
Antioxidants (Basel, Switzerland) 2020; 9:
91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Adetunji MO
Cell reports 2020; 33: 108271
